Boehringer Ingelheim Vetmedica Inc. plans to move its North American animal health headquarters from St. Joseph to the Atlanta area.
Boehringer Ingelheim’s efforts to acquire the animal health subsidiary of Sanofi precipitated the move. For Boehringer Ingelheim to acquire Merial, valued at more than $12.7 billion, it swapped its consumer health care business with Sanofi. The deal still requires Federal Trade Commission approval.
Once the Sanofi deal closes, expected in January, Boehringer Ingelheim’s animal health leadership will relocate to a Merial facility in Duluth, Ga., the company said in a release. However, most of the employees in St. Joseph will be unaffected, and the location “will continue as a critical part of the integrated business,” according to the release.
Read more: Kansas City Business Journal